The role of atrial dilatation in development of chronic atrial fibrillation

Informations projet

NEUBERGER, HANS-RUPR

N° de convention de subvention: QLG1-CT-2000-51236

Projet clôturé

Date de début 1 Janvier 2001

Date de fin 31 Decembre 2002

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 140 600,00

Contribution de l’UE € 140 600,00

Coordonné par

UNIVERSITY OF MAASTRICHT
Netherlands

Objectif

The project investigates whether chronic a trial dilatation plays a causal role in a trial fibrillation. It uses a new method in a well-established goat model and will help to develop effective therapeutic strategies against this important arrhythmia.

Champ scientifique

• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases › cardiac arrhythmia

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

UNIVERSITY OF MAASTRICHT

• Contribution de l’UE: Aucune donnée
• Adresse: Universiteitssingel 50 ; 6200 MB MAASTRICHT ; Pays-Bas
• Coût total: Aucune donnée